Company · CIK 1811764

# POINT Biopharma Global Inc.

| CIK | [1811764](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001811764) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | IN |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-08-20 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-265981 | Shelf Effective | 2022-07-01 | 2023-12-29 | 5 |
| 333-258325 | Registered company Effective | 2021-07-30 | 2022-07-07 | 4 |
| 333-239196 | IPO Final prospectus | 2020-06-15 | 2020-07-09 | 6 |

## Filings

 18

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2023-12-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1811764/999999999524000028/9999999995-24-000028-index.htm) Declared effective | 333-265981 | 9999999995-24-000028 |
| 2023-12-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1811764/999999999524000026/9999999995-24-000026-index.htm) Declared effective | 333-254600 | 9999999995-24-000026 |
| 2022-09-14 | [424B5](https://www.sec.gov/Archives/edgar/data/1811764/000162828022024904/0001628280-22-024904-index.htm) Shelf takedown | 333-265981 | 0001628280-22-024904 |
| 2022-09-13 | [424B5](https://www.sec.gov/Archives/edgar/data/1811764/000162828022024854/0001628280-22-024854-index.htm) Shelf takedown | 333-265981 | 0001628280-22-024854 |
| 2022-07-11 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1811764/999999999522002019/9999999995-22-002019-index.htm) Declared effective | 333-265981 | 9999999995-22-002019 |
| 2022-07-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1811764/999999999522001977/9999999995-22-001977-index.htm) Declared effective | 333-258325 | 9999999995-22-001977 |
| 2022-07-01 | [S-3](https://www.sec.gov/Archives/edgar/data/1811764/000162828022018378/0001628280-22-018378-index.htm) Shelf registered | 333-265981 | 0001628280-22-018378 |
| 2022-03-28 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1811764/999999999522000731/9999999995-22-000731-index.htm) Declared effective | 333-258325 | 9999999995-22-000731 |
| 2021-08-05 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1811764/999999999521003069/9999999995-21-003069-index.htm) Declared effective | 333-258325 | 9999999995-21-003069 |
| 2021-07-30 | [S-1](https://www.sec.gov/Archives/edgar/data/1811764/000110465921098307/0001104659-21-098307-index.htm) Registration filed | 333-258325 | 0001104659-21-098307 |
| 2021-06-09 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1811764/999999999521002271/9999999995-21-002271-index.htm) Declared effective | 333-254600 | 9999999995-21-002271 |
| 2020-07-09 | [424B4](https://www.sec.gov/Archives/edgar/data/1811764/000104746920004057/0001047469-20-004057-index.htm) Final prospectus | 333-239196 | 0001047469-20-004057 |
| 2020-07-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1811764/999999999520001692/9999999995-20-001692-index.htm) Declared effective | 333-239196 | 9999999995-20-001692 |
| 2020-07-07 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1811764/000104746920004002/0001047469-20-004002-index.htm) Amendment | 333-239196 | 0001047469-20-004002 |
| 2020-07-06 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1811764/000104746920003963/0001047469-20-003963-index.htm) Amendment | 333-239196 | 0001047469-20-003963 |
| 2020-06-29 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1811764/000104746920003885/0001047469-20-003885-index.htm) Amendment | 333-239196 | 0001047469-20-003885 |
| 2020-06-15 | [S-1](https://www.sec.gov/Archives/edgar/data/1811764/000104746920003606/0001047469-20-003606-index.htm) Registration filed | 333-239196 | 0001047469-20-003606 |
| 2020-05-14 | [DRS](https://www.sec.gov/Archives/edgar/data/1811764/000091205720000160/0000912057-20-000160-index.htm) Draft made public | 377-03172 | 0000912057-20-000160 |

[All filings of this company](https://equitycapital.markets/filings?cik=1811764) · [CSV](https://equitycapital.markets/filings.csv?cik=1811764)

---
Source page: https://equitycapital.markets/company/1811764 · Data: U.S. SEC EDGAR · CC BY 4.0